87 related articles for article (PubMed ID: 23128886)
1. [Study of patients with gout: clinical features in the last 2 years of monitoring].
Sicras-Mainar A; Viana Álvarez R; Galera Llorca J; Granell Villalón M; Navarro-Artieda R
Gac Med Mex; 2012; 148(5):448-56. PubMed ID: 23128886
[TBL] [Abstract][Full Text] [Related]
2. Resource use and economic impact of patients with gout: a multicenter, population-wide study.
Sicras-Mainar A; Navarro-Artieda R; Ibáñez-Nolla J
Reumatol Clin; 2013; 9(2):94-100. PubMed ID: 23313534
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with acute gout attacks in normouricaemic gout patients receiving allopurinol: a retrospective study.
So MW; Lee SG; Kim YG; Lee CK; Yoo B
Scand J Rheumatol; 2011 Nov; 40(6):444-7. PubMed ID: 21916803
[TBL] [Abstract][Full Text] [Related]
4. First acute gout attacks commonly precede features of the metabolic syndrome.
Hernández-Cuevas CB; Roque LH; Huerta-Sil G; Rojas-Serrano J; Escudero A; Perez LL; Collantes-Estevez E; Vázquez Mellado J
J Clin Rheumatol; 2009 Mar; 15(2):65-7. PubMed ID: 19265347
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study.
Trifirò G; Morabito P; Cavagna L; Ferrajolo C; Pecchioli S; Simonetti M; Bianchini E; Medea G; Cricelli C; Caputi AP; Mazzaglia G
Ann Rheum Dis; 2013 May; 72(5):694-700. PubMed ID: 22736095
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of gout in primary care.
Rakieh C; Conaghan PG
Practitioner; 2011 Dec; 255(1746):17-20, 2-3. PubMed ID: 22272526
[TBL] [Abstract][Full Text] [Related]
7. Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks.
Saseen JJ; Agashivala N; Allen RR; Ghushchyan V; Yadao AM; Nair KV
Rheumatology (Oxford); 2012 Nov; 51(11):2004-12. PubMed ID: 22829689
[TBL] [Abstract][Full Text] [Related]
8. Impact of a rheumatology consultation service on the diagnostic accuracy and management of gout in hospitalized patients.
Barber C; Thompson K; Hanly JG
J Rheumatol; 2009 Aug; 36(8):1699-704. PubMed ID: 19567626
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
Alvarez-Nemegyei J; Cen-Pisté JC; Medina-Escobedo M; Villanueva-Jorge S
J Rheumatol; 2005 Oct; 32(10):1923-7. PubMed ID: 16206348
[TBL] [Abstract][Full Text] [Related]
10. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
[TBL] [Abstract][Full Text] [Related]
12. Serum urate levels and gout flares: analysis from managed care data.
Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
[TBL] [Abstract][Full Text] [Related]
13. Gout in systemic lupus erythematosus and overlap syndrome - a hospital-based study.
Ho HH; Lin JL; Wu YJ; Yu KH; Chen JY; Luo SF
Clin Rheumatol; 2003 Oct; 22(4-5):295-8. PubMed ID: 14579159
[TBL] [Abstract][Full Text] [Related]
14. Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007.
Elliot AJ; Cross KW; Fleming DM
Ann Rheum Dis; 2009 Nov; 68(11):1728-33. PubMed ID: 19029167
[TBL] [Abstract][Full Text] [Related]
15. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
[TBL] [Abstract][Full Text] [Related]
16. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.
Zandman-Goddard G; Amital H; Shamrayevsky N; Raz R; Shalev V; Chodick G
Rheumatology (Oxford); 2013 Jun; 52(6):1126-31. PubMed ID: 23392592
[TBL] [Abstract][Full Text] [Related]
17. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study.
Hunter DJ; York M; Chaisson CE; Woods R; Niu J; Zhang Y
J Rheumatol; 2006 Jul; 33(7):1341-5. PubMed ID: 16758506
[TBL] [Abstract][Full Text] [Related]
18. [Gout in Togolese patients].
Mijiyawa M; Djagnikpo K; Dagbovie K; Agbetra A
Rev Rhum Mal Osteoartic; 1992; 59(7-8):473-7. PubMed ID: 1485137
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout.
van Lieshout-Zuidema MF; Breedveld FC
J Rheumatol; 1993 Aug; 20(8):1383-5. PubMed ID: 8230024
[TBL] [Abstract][Full Text] [Related]
20. Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.
Hatoum H; Khanna D; Lin SJ; Akhras KS; Shiozawa A; Khanna P
Postgrad Med; 2014 Mar; 126(2):65-75. PubMed ID: 24685969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
